Lenalidomide plus Rituximab as Initial Treatment for Mantle-Cell LymphomaJia Ruan, John P. Leonard, Peter Martin et al.|New England Journal of Medicine|2015Cited by 237
Control of Simultaneous Outbreaks of Carbapenemase-Producing Enterobacteriaceae and Extensively Drug-Resistant<i>Acinetobacter baumannii</i>Infection in an Intensive Care Unit Using Interventions Promoted in the Centers for Disease Control and Prevention 2012 Carbapenemase-Resistant Enterobacteriaceae ToolkitCosti D. Sifri, Heather L. Cox, Jessica Lewis et al.|Infection Control and Hospital Epidemiology|2014Cited by 64
Sustained Remission with the Combination Biologic Doublet of Lenalidomide Plus Rituximab As Initial Treatment for Mantle Cell Lymphoma: A Multi-Center Phase II Study ReportJia Ruan, John P. Leonard, Peter Martin et al.|Blood|2014Cited by 18
Combination Biologic Therapy Without Chemotherapy As Initial Treatment For Mantle Cell Lymphoma: Multi-Center Phase II Study Of Lenalidomide Plus RituximabJia Ruan, John P. Leonard, Peter Martin et al.|Blood|2013Cited by 9